Skip to main
LABP
LABP logo

Landos Biopharma (LABP) Earnings Dates & Reports

Landos Biopharma (LABP) Most Recent Earnings

Report DateMay 9, 2024
Period EndingQ1 2024
Est. EPS-$1
Actual EPS-$1.43
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Landos Biopharma (LABP) Earnings per Share (EPS) History

Signup for full access
Browse free

Landos Biopharma (LABP) Latest Earnings

The value each LABP share was expected to gain vs. the value each share gained.

Landos Biopharma (LABP) reported its most recent earnings on May 9, 2024 for Q1 2024, posting earnings per share (EPS) of -$1.43. This exceeded analysts' expectations of -$1 by 43.00%, marking a Miss.

For comparison, Landos Biopharma reported EPS of -$0.90 in the same quarter last year.

The company is expected to announce its next earnings report on 05/09/2024, with analysts projecting an EPS of $0.

Landos Biopharma (LABP) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2024May 9, 2024
-$1.00-$1.43+43.00%
Q4 2023Mar 21, 2024
-$0.91-$0.99+8.79%
Q3 2023Nov 9, 2023
-$0.88-$0.94+6.82%
Q2 2023Aug 9, 2023
-$1.10-$0.63-42.73%
Q1 2023May 12, 2023
-$0.90-$0.900.00%

Landos Biopharma (LABP) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Landos Biopharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Mar 21, 2024
Nov 9, 2023
Aug 9, 2023
May 12, 2023

Landos Biopharma (LABP) Earnings FAQs

Landos Biopharma (LABP) last reported earnings on May 9, 2024 for Q1 2024, posting an EPS of -$1.43, which Miss the estimate of -$1 by 43.00%.

For Q1 2024, Landos Biopharma (LABP) reported an EPS of -$1.43, missing analysts' estimate of -$1 by 43.00%.

For Q1 2024, Landos Biopharma (LABP) Miss expectations with an actual EPS of -$1.43 vs. an estimated EPS of -$1.

Following the last earnings report on May 9, 2024, Landos Biopharma (LABP)'s stock price moved — from — to —.

The next Landos Biopharma (LABP) earnings call is scheduled for May. 9, 2024, where executives will discuss financial results and outlook.

Landos Biopharma (LABP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.